The Prognostic Significance of Combined Pretreatment Fibrinogen and Neutrophil-Lymphocyte Ratio in Various Cancers: A Systematic Review and Meta-Analysis

<div>Funnel plot of sensitivity analysis. (a) Sensitivity analysis for OS. (b) Sensitivity analysis for DFS/PFS.</div>

Disease Markers

fig4

Figure 4

Figure 4: The Prognostic Significance of Combined Pretreatment Fibrinogen and Neutrophil-Lymphocyte Ratio in Various Cancers: A Systematic Review and Meta-Analysis 

Figure 4 | The Prognostic Significance of Combined Pretreatment Fibrinogen and Neutrophil-Lymphocyte Ratio in Various Cancers: A Systematic Review and Meta-Analysis 